Optimal Dosage of Dexamethasone in COVID-19 Treatment

Exploring the debate between using 6 or 12 milligrams of dexamethasone in COVID-19 treatment, considering individual patient conditions and interleukin-6 receptor antagonist availability. The chapter discusses the shift towards higher dexamethasone doses, especially in regions without IL-6 inhibitors, and the global variations in dosages used during the pandemic.